Mycophenolate Mofetil-d4 (Synonyms: MMF-d4) |
カタログ番号GC47712 |
ミコフェノール酸モフェチル-d4 は、ミコフェノール酸モフェチルと標識された重水素です。ミコフェノール酸モフェチル (RS 61443) は、ミコフェノール酸のモルホリノエチルエステル プロドラッグです。ミコフェノール酸モフェチルは、イノシン一リン酸デヒドロゲナーゼ (IMPDH) の阻害を介して de novo プリン合成を阻害します。ミコフェノール酸モフェチルは、T 細胞と B 細胞の両方に関与する選択的なリンパ球抗増殖効果を示し、抗体形成を防ぎます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1132748-21-0
Sample solution is provided at 25 µL, 10mM.
Mycophenolate mofetil-d4 is intended for use as an internal standard for the quantification of mycophenolate mofetil by GC- or LC-MS. Mycophenolate mofetil is a prodrug form of mycophenolic acid .1,2,3 In vivo, mycophenolate mofetil (12.5 mg/kg) increases duration of transplant motor activity in a rabbit model of retroperitoneal heterotopic heart transplantation.1 It eliminates formation of microbleeds and hemorrhages in the cerebrum of stroke-prone spontaneously hypertensive rats.2 Mycophenolate mofetil also lowers mean arterial pressure (MAP) and reduces urinary albumin excretion and glomerulosclerosis, markers of renal damage, in a mouse model of systemic lupus erythematosus (SLE).3
1.AygÜn, F., Efe, D., and Durgut, K.Comparison of MMF with prednisone in terms of rejection and duration of activity of transplant in rabbits that underwent retroperitoneal heterotopic heart transplantationCardiovasc. J. Afr.26(3)104-108(2015) 2.Dhande, I.S., Zhu, Y., Braun, M.C., et al.Mycophenolate mofetil prevents cerebrovascular injury in stroke-prone spontaneously hypertensive ratsPhysiol. Genomics49(3)132-140(2017) 3.Taylor, E.B., and Ryan, M.J.Immunosuppression with mycophenolate mofetil attenuates hypertension in an experimental model of autoimmune diseaseJ. Am. Heart Assoc.6(3)e005394(2017)
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *